Breast Lift in DK
Breast Lift in DK section, includes general infrmation about Breast Lift Procedure, Breast Lift DK Local News, Breast Lift DK Surgeon Locator and other Breast Lift related material.
Breast Lift Procedure
A mastopexy or breast lift is a surgical procedure performed to reshape the breast and return it to a more youthful position. Drooping of the breast may occur after pregnancy as well as aging. Frequently a breast implant may be used in conjunction with a breast lift in order to achieve better results. Depending on the amount of breast lifting that needs to be accomplished, different techniques may be used that involve different incisions. Generally, the more lifting that is required, the larger the incision (and therefore the scar).
Other Breast Lift Procedures
All Breast Procedures
Breast Lift DK (current)
DK Breast Reduction
DK Breast Implants
DK Implant Removal
DK Armpit Incision
More DK info...
Plastic Surgery News...
- According to a study published in the Journal of Clinical Oncology, darbepoetin alfa does not statistically significantly reduce the need for transfusions and reduces survival time for cancer patients with anaemia and not receiving chemotherapy or radiotherapy.
Researchers evaluated the safety and efficacy of the use of darbepoetin in a total of 989 patients randomised to receive darbepoetin 6.75mcg/kg every 4 weeks (n=517) or placebo (n=472). Patients received up to 16 weeks of treatment followed by an end-of-study visit at week 19 and 2 years of follow-up for survival. Patients who completed 16 weeks of treatment could receive the same blinded treatment every 4 weeks for a further 16 weeks with an end-of-study visit at week 35. The primary end point was all occurrences of transfusions from weeks 5 through 17, and safety end points included incidence of adverse events and survival.
According to the researchers, the incidence of transfusions between weeks 5 and 17 was lower in the darbepoetin group (19.1% vs. 23.9%) but was not statistically significantly different from that of placebo (absolute difference -5.0, 95% CI -10.4 to 0.4, p = 0.068).
Additionally, darbepoetin was associated with an increased incidence of cardiovascular and thromboembolic events and more deaths during the initial 16-week treatment period, and long-term survival data demonstrated statistically significantly poorer survival in patients treated with darbepoetin versus placebo ((HR = 1.22; 1.03 to 1.45; P = 0.022).
The researchers therefore also conclude that this study does not support the use of erythropoiesis-stimulating agents in this subset of patients with anaemia of cancer.
- "Cost Analysis Impact for the 'Health Care for America' Proposal," Lewin Group: The report analyzes the potential costs of a proposal that would create a new national health insurance pool modeled after Medicare that calls for employers, individuals and the federal government to share responsibility. According to the report, the proposal would reduce the number of uninsured U.S. residents by 46.